These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11961974

  • 1. [A critical evaluation of side effect data on COX-2 inhibitors].
    Pomp E.
    Tidsskr Nor Laegeforen; 2002 Feb 20; 122(5):476-80. PubMed ID: 11961974
    [Abstract] [Full Text] [Related]

  • 2. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov 20; 38(11):81-6. PubMed ID: 11138599
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 20; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [Abstract] [Full Text] [Related]

  • 4. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H, Amouri A, Cheikh I, Kchaou M, Ouerghi H, Ben Mami N, Ben Ammar A.
    Tunis Med; 2002 Aug 20; 80(8):427-33. PubMed ID: 12703120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
    Fung HB, Kirschenbaum HL.
    Clin Ther; 1999 Jul 20; 21(7):1131-57. PubMed ID: 10463513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.
    Am J Gastroenterol; 2001 Apr 20; 96(4):1019-27. PubMed ID: 11316141
    [Abstract] [Full Text] [Related]

  • 11. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ, Wentworth C, Burke TA, Makuch RW.
    Pharmacoepidemiol Drug Saf; 2004 May 20; 13(5):277-87. PubMed ID: 15133778
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
    Nguyen A, Chaiton A.
    Can Fam Physician; 2001 Jul 20; 47():1398-400. PubMed ID: 11494927
    [No Abstract] [Full Text] [Related]

  • 13. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

  • 14. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Lems WF, van de Laar MA, Bijlsma JW.
    Ned Tijdschr Geneeskd; 2001 Jun 02; 145(22):1044-7. PubMed ID: 11414163
    [Abstract] [Full Text] [Related]

  • 15. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 02; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.